In this work, we have studied the immunohistochemical expression of the kinase PINK1 in a specific subset of patients with colorectal adenocarcinomas, consisting only of those patients who underwent curative surgical resection of their CRLM, to better describe molecular alterations in CRCs at this stage of advanced disease. The gene discussed is PINK1; the disease is colorectal adenocarcinoma.